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Abstract
Background: Echovirus 14 (E-14) causes various clinical recognized syndromes, mostly with gastrointestinal
syndrome and paralysis. The current study summarized the Shandong E-14 strains isolated from a 26-year acute
flaccid paralysis (AFP) surveillance, and elucidated the characterization of phylogenetic and phylogeographic
relationships of E-14 worldwide.
Results: As a predominant serotype circulating in AFP surveillance, phylogenetic analysis showed that E-14
exhibited both time and geographic subdivision worldwide. In order to know the evolutionary history and spatial
temporal dynamics of E-14, evolutionary phylogeography was reconstructed using BEAST and SPREAD software
based on the VP1 sequences. The time of the most recent common ancestor of E-14 was estimated around 85
years and evolved with 9.17 × 10−3 substitutions/site/year. Phylogeographic analysis suggested that two regional
transmissions of E-14 were mainly detected, with one located between Europe and Africa countries and the other
was in the Asia-Pacific region.
Conclusions: Our study investigates the molecular evolution and phylogeographic of E-14, and brings new insight
to the dispersal of E-14 worldwide. Regional transmission was mainly detected and Australia may be responsible for
the spread of E-14 in recent years.
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Background
Enteroviruses (EVs) are common human pathogens be-
longing to the genus Enterovirus, family Picornaviridae.
Most EV infections are usually asymptomatic, but some-
times they are associated with diverse clinical syndromes
ranging from minor febrile illness to severe, potentially
fatal diseases such as encephalitis, paralysis, myocarditis
and neonatal enteroviral sepsis [1, 2]. EVs have tradition-
ally been detected based on virus isolation in cell cultures
and subsequently serotyped by serum neutralization test,
and were classified into echoviruses (E), coxsackieviruses
(CV) group A and B, and polioviruses. Currently, based
on the phylogenetic relationships in multiple genome re-
gions, International Committee on Taxonomy of Viruses
reclassified EVs into 12 species: EV-A to EV-H, EV-J and
rhinovirus A, B and C [3]. Of these species, seven (EV-A
to EV-D and rhinovirus A, B, C) of the EV species infect
humans while remaining infect non-human animals.
Echovirus 14 (E-14) was first isolated from a hospital-
ized patient suffering from aseptic meningitis syndrome
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in 1954 [4] and had been classified as a member of EV-
B. In contrast to other common EVs such as EV-A71
and CV-A16, both of which are categorized as EV-A and
are major etiological agents for the widely spread hand,
foot and mouth disease (HFMD) [5–7], E-14 is consid-
ered relatively rare as it less likely to cause worldwide
occurrences of clusters and outbreaks. However, epi-
demics of E-14 infection had been observed in Europe
and Asia in the 1960s [8–11]. Similarly, association of E-
14 with many clinical recognized syndromes such as
gastrointestinal syndrome [8–10], acute serous meningi-
tis [12], paralysis [13], fatal neonatal hepatic necrosis
[14], aseptic meningitis [11, 15] has been reported previ-
ously. In recent years, E-14 is more than detected in an
outbreak or epidemic caused by other pathogens [16, 17]
or exhibited sporadic infection in conventional viro-
logical surveillance [18–20].
As a coastal province, Shandong has a population of
about 96 million and major ports that could potentially
serve as portals for importation of exogenous viruses. The
acute flaccid paralysis (AFP) surveillance, developed for
polio eradication program, was launched in Shandong in
1988. Currently, the AFP surveillance has been conducted
in all 138 counties of Shandong province and more than
600 sentinel hospitals were included. AFP surveillance can
obtain non-polio enterovirus (NPEV) strains as a side
benefit and produce baseline data of local NPEV distribu-
tion and a genetic overview [21]. Our previous study dem-
onstrated continuous AFP surveillance provided valuable
information on the circulation and emergence of different
EV types in the context of limited EV surveillance in
China [20]. In this present study, we investigated the
genetic characterization of E-14 strains isolated from
Shandong AFP surveillance during 1988–2013. Phylogen-
etic and phylogeographic analysis were combined to
elucidate the evolution relationship and spatiotemporal
dynamics of E-14 worldwide.
Results
Virus isolation
The annual numbers of reported AFP cases (contacts),
NPEV and E-14 isolates were illustrated in Fig. 1. From
1988 to 2013, a total of 962 NPEV isolates were identi-
fied based on the molecular typing method in Shandong
AFP surveillance, with E-14 serotype having the highest
number of the total strains. In our study, E-14 was first
detected in 1993. As the AFP surveillance and report in
China was not so active in the early 1990s, no E-14 iso-
lates were detected for three consecutive years (1994–
1996), and numbers of E-14 and NPEV strains increased
substantially since 1997. It was worth noting that the
proportion of E-14 in contacts is higher than in AFP
cases is due to the formation of EV transmission
chains, for the rest contacts were probable positive as
one infected E-14. The mean constituent rate of E-14
was 7.6% (73/962), and the highest constituent rate
reached to 23.1% (9/39) in 2004. Consequently, E-14
under EV-B persisted to be the most commonly
isolated serotype circulating in a long term trend in
our AFP surveillance.
Fig. 1 Annual numbers of AFP cases (contacts), NPEV and E-14 isolates in Shandong AFP surveillance from 1988 to 2013
Chen et al. BMC Genomics  (2017) 18:48 Page 2 of 10
Homology and phylogenetic analysis
Excluding the same (100% VP1 nucleotide homology)
strains and co-infection strain, we used 73 E-14 strains
isolated from Shandong province for phylogenetic ana-
lysis based on the VP1 sequence. Homologous compari-
son showed 73 Shandong E-14 isolates had 79.8–99.8%
(94.9–100% amino acid sequence identities) VP1 nucleo-
tide sequence identities among themselves and the over-
all mean p-distance value was 0.142. Phylogenetic
analysis was conducted on partial VP1 coding region (nt
2596–2880 on prototype strain Tow) of Shandong iso-
lates with global reference E-14 sequences. Overall, the
global E-14 sequences were distributed into two major
partitions identified by lineage I and II. Compared with
the global E-14 strains, all Shandong E-14 isolates fell
into a major phylogenetic lineage (lineage I) that in-
cluded strains from China (Fig. 2). This is probably due
to the more frequent population exchange in domestic
than the rest of the world, as the international exchange
needs to perform a more cumbersome procedure in
China. Therefore, isolates from China studied here
existed distinct genetic relationship with other world-
wide E-14 strains. We also suggested that E-14 strains
from China had the same putative ancestor relative to
the strains from other regions of the world.
Within lineage I, all sequences segregated into three
distinct genomic groups (A-C). Homologous analysis
revealed 79.9–88.7, 80.8–84.7, 79.8–86.3% nucleotide
identities between groups A and B, A and C, B and C,
respectively. Strains in these three groups showed high
correlation with the time of isolation, and a limited
temporal overlap was observed among these three
groups that circulated in Shandong and other provinces
in China. The phylogenetic analysis showed that strains
in lineage II mainly from India, Australia, Georgia,
Netherlands, France and Bangladesh. For the 26 India
strains isolated from 2007 to 2011, 20 strains segre-
gated into group F with strains from Australia, while
the other 6 strains isolated from 2008 to 2011 belonged
to group E in the phylogenetic tree.
Fig. 2 Phylogenetic tree based on partial E-14 VP1 sequences of Shandong isolates and global strains. Strains are color-coded and represented
group A-F according to their phylogenetic relationship. Circles indicate strains detected in the present study; triangles indicate strains isolated
from other provinces in China. Abbreviations in isolate names are as follows: CHN-SD, Shandong province in China; USA, United States of America;
AUS, Australia; IN, India; FRA, France; BAN, Bangladesh; MAD, Madagascar; NL, Netherlands; NIE, Nigeria; CAF, Central African Republic; GRE, Greece;
GEO, Georgia; KEN, Kenya; PAK, Pakistan
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Phylogeographic analysis
In order to estimate the divergence time and substitu-
tion rate of E-14 more accurately, the complete VP1 se-
quence from Shandong province and from global were
selected to analyze with the Bayesian MCMC method.
Different models were used for data analysis, and all of
the results were summarized in Table 1. Considering
both the Harmonic Mean and the AICM model selec-
tion results, we concluded that the UCLD relaxed clock
model was a significantly better fit model than the strict
clock model for each of the parameter. Hence, the com-
bination of UCLD relaxed clock model and exponential
growth (EG) model were recommended for this study,
and the estimated nucleotide substitution rate for global
E-14 was 9.17 × 10−3 substitutions/site/year (95% HPD:
7.67 × 10−3–10.80 × 10−3). Estimated the tMRCA of global
E-14 strains was August 1928 (95% HPD: February 1910–
May 1944), China strains (lineage 1) was June 1972 (95%
HPD: February 1965–June 1979), and the strains isolated
in other regions of the world (lineage 2) was September
1967 (95% HPD: January 1958–August 1976).
Results of the MCC tree (Fig. 3) constructed by Tree
Annotator showed that Shandong E-14 isolates segre-
gated into three groups, which were consist with the
phylogenetic tree in Fig. 2. Phylogenetic analysis sug-
gested the origin of global E-14 could be in the USA.
Lineage 1 represented strains from China (including all
Shandong isolates), and the data indicated that E-14 in
China shared the same putative ancestor. Lineage 2
represented the strains from other regions of the world,
and the strains were gradually radiated into France,
India and Bangladesh. Our results showed that strains
in Australia may have also played a dominant role in
spreading this lineage.
The geographic dispersal of the global E-14 strains
was conducted with the partial VP1 sequences and was
shown in Fig. 4 (Additional files 1 and 2). Phylogeo-
graphic reconstruction was able to identify a single loca-
tion for the origin of the global E-14 strains in the USA
around March 1928. The virus crossed the Atlantic
Ocean and arrived in Greece in 1951, and then spread
following two distinct routes: i) to the East arrived in
Australia around 1958 and ii) to the South arrived in
Central African Republic around November 1978. As E-
14 strains arrived in Australia, the virus was latent in
this region and spread to India, Georgia, Bangladesh and
France in about 40 years. Viral strains that from
Australia arrived in Guangdong province of China in an
early time, and then showed a relatively quick diffusion
rate to Shandong and Zhejiang provinces. In general, E-
14 strains from the USA and Australia were the most
probable source for the introduction of E-14 strains to
European countries and the Asia-Pacific region, respect-
ively, with all BF > 19.0.
Discussion
Compared with many EV serotypes which can lead to
serious illness, E-14 is considered relatively rare as it less
likely to cause worldwide occurrences of clusters or out-
breaks. To the best of our knowledge, no detailed mo-
lecular epidemiology study was carried out based on a
large number of E-14 sequences. Owning to the launch
of the Global Poliomyelitis Eradication Initiative, we had
accumulated a significant number of E-14 sequences
associated with AFP surveillance which was developed
for casting a wider net for poliovirus detection in
Shandong since 1988. For the detection of circulating
EVs, AFP surveillance has also provided a major source
Table 1 Estimators of phylogeographic analysis on E-14 strains under different molecular clock and coalescent model combinations
Parameter Estimator of the parameter (95% HPD interval) under different molecular combinations
SC & Const SC & Exp SC & BSP UCLD & Log UCLD & Exp UCLD & BSP
Harmonic Mean −18271.839 −18253.871 −20602.113 −18187.626 −18169.821 −20529.023
AICM 36747.72 36686.69 41416.886 36765.743 36742.314 41489.35
tMRCA (global E-14) 88.06 (78.14,98.49) 87.74 (77.86,97.49) 86.29 (77.15,96.05) 85.48 (70.22,103.77) 85.31 (69.64,103.79) 83.02 (68.20,100.25)
tMRCA (Lineage 1) 43.44 (39.22,47.96) 43.52 (39.36,48.18) 42.64 (38.81,46.97) 41.26 (34.69,48.50) 41.46 (34.45,48.79) 40.80 (34.92,47.36)
tMRCA (Lineage 2) 46.87 (41.54,52.31) 47.04 (41.77,52.62) 45.92 (41.07,51.20) 46.32 (37.09,56.15) 46.15 (37.33,55.94) 44.41 (36.14,53.59)
tMRCA (group 1) 32.31 (28.95,35.75) 32.36 (29.09,35.90) 31.73 (28.66,34.97) 31.50 (26.51,37.04) 31.46 (26.35,36.96) 31.38 (26.61,36.66)
tMRCA (group 2) 29.85 (26.57,33.27) 29.89 (26.70,33.38) 29.45 (26.36,32.67) 27.41 (22.47,32.85) 27.40 (22.49,32.77) 28.09 (23.16,33.32)
tMRCA (group 3) 29.63 (27.53,31.72) 29.70 (27.70,31.97) 29.53 (27.58,31.60) 28.45 (25.42,31.64) 28.46 (25.26,31.61) 28.85 (25.95,32.21)
tMRCA (group 4) 46.43 (40.44,52.43) 46.62 (40.92,52.85) 45.63 (40.19,51.24) 45.47 (36.29,56.13) 45.30 (35.46,55.05) 43.72 (35.19,53.39)
tMRCA (group 5) 38.91 (33.45,44.89) 39.05 (33.61,44.99) 38.33 (33.06,43.68) 34.62 (27.34,43.15) 34.43 (27.34,42.15) 33.55 (27.35,41.16)
Mean evolutionary rate 8.44 (7.42,9.48) 8.38 (7.39,9.46) 8.57 (7.61,9.58) 9.14 (7.65,10.70) 9.17 (7.67,10.80) 9.30 (7.80,10.80)
The best fitting model combination was highlighted in boldface. The molecular clock models used were the strict molecular clock (SC) and the uncorrelated log-
normal distributed (UCLD) relaxed molecular clock. Coalescent models used were the parametric Constant model (Const), Exponential model (Exp), Logistic model
(Log) and Bayesian skyline plot model (BSP). 95% HPD 95% highest posterior density, tMRCA the most recent common ancestor, AICM the Akaike information
content model selection method
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of information in China, as specialized EV surveillance
based on other approaches or populations was still very
limited. In addition, studies conducted in other countries
[18, 22–27] also described the NPEV serotypes identified
from the AFP surveillance, and the information had
attracted more attention of the scholars worldwide.
Although E-14 may cause mild to severe neurological
disorders as reported from Russia [12], France [9, 10],
Fig. 3 Maximum clade credibility (MCC) tree of the complete VP1 sequences of E-14 strains throughout the world visualized in FigTree. The colors
of the branches corresponded to their probable geographic location. The intervals of branch reflect the 95% highest posterior density (HPD) intervals
for the branch height. E-14 isolates from Shandong segregated into three groups (1, 2 and 3). Abbreviations of geographic location are shown as
described in the legend of Fig. 2
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Italy [8] and Japan [11, 13, 15], unfortunately, no clinical
information, molecular epidemiology and disease correl-
ation of this serotype have been reported. This study,
which was performed a comprehensive molecular epide-
miologic analysis of Shandong E-14 isolates, was feasible
because of the large number of AFP database during the
last 26 years in Shandong, China. During 1990–2013, a
total of 10322 AFP cases and contacts were reported,
and 958 NPEV isolates were obtained from stool speci-
mens in Shandong AFP surveillance [20]. A total of 53
NPEV serotypes were identified, serotypes such as E-6,
E-14 and EV-A71 were the most commonly reported. It
should also be notified that no EV-D68 strains were
detected in our AFP surveillance, although this EV sero-
type was associated with AFP and other neurological
complications. The proportion of E-14 isolated in this
study was high (7.6%) as compared to other identified
NPEV serotypes [20]. Additionally, E-14 was also found
a prevalent EV serotype with AFP surveillance in other
regions of the world [18, 19, 28]. Consequently, all these
findings suggest E-14 as the possible causative agent of
paralysis, and the molecular epidemiologic analysis of
E-14 is still necessary.
EVs are well known for their high genome plasticity,
due to both high mutation and recombination rates. In
this study, we analyzed the global E-14 genetic diversity,
of 73 isolates from Shandong and 54 strains isolated in
twelve different countries. The phylogenetic tree (Fig. 2)
revealed that E-14 strains clustered in both time and re-
gional distributions. For E-14 isolated in China, strains
in group C and B were from 1993 to 2006 and 2000 to
2010, respectively and there were 10 and 6 years had
passed since the last isolation in these two groups. The
isolation years of group A spanned from 1993 to 2014,
revealing a long time circulation of this group in Shan-
dong region. Moreover, it is obvious that E-14 isolates
belonging to group B and C may have been disappeared
after circulating for a period of time and was replaced by
group A. Viruses in group A may have become the dom-
inant group circulating in China. Alternatively, the infor-
mation on Chinese E-14 isolates is limited, and more
sequences are needed to determine domestic E-14
phylogenetic relationships.
We used a phylogenetic molecular clock approach to
further infer the historical background and geographic
diffusion of global E-14 strains. The MCC tree (Fig. 3)
constructed was congruent with the results observed in
phylogenetic analysis (Fig. 2). It was perceived by Bayesian
MCMC evolutionary analysis that E-14 strains were circu-
lated for about 80 years in the world. Moreover, E-14
strains isolated in China may be the product of geographic
segregation and has evolved independently in China for a
long time. Two observations suggest that the common an-
cestor of global E-14 lineages existed in the USA. First,
USA was the first country reported to detect E-14 [11]
and second, the USA strain is phylogenetically more di-
verse within the phylogenetic tree (Fig. 2) and the MCC
tree (Fig. 3) than those from elsewhere. However, these
observations may reflect differences in AFP surveillance
intensity among countries and more information is
Fig. 4 Geographic distribution and inferred dynamics of global E-14 strains. The map was reconstructed using the ArcGIS (http://www.esri.com/),
and was identical to the original image created by the SPREAD and GoogleTM Earth. Arrows indicate the inferred routes of spread of global E-14.
The number represented the time when E-14 arrived. Abbreviations of geographic location are shown as described in the legend of Fig. 2
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required before we can conclude that E-14 was introduced
to the USA multiple times from other regions. Interest-
ingly, our results indicate that circulation of E-14 in
Australia is very dynamic, as the virus likely to be the res-
ervoir for evolutionary origin of E-14 in the world. The re-
sults that the nucleotide substitution rate of E-14 VP1
gene was similar to other EV serotypes [29–34] also sug-
gested the evolutionary pressure acting on E-14 existed no
significant difference with other serotype strains.
A particular focus of this study was to determine the
phylogeographic relationship between E-14 collected
from Shandong province and compare these with those
from other countries. To our knowledge, the current
study is the first applying the Bayesian phylogeographic
reconstruction approach to gain insight into the emer-
gence and spread of E-14 strains worldwide [35]. The
phylogeographic analysis revealed that the transmission
of E-14 in China likely originated from the Australia,
and then the endemic circulation was observed without
spreading to foreign countries. However, E-14 strains in
China and Australia have no direct evolutionary rela-
tionship according to the phylogenetic analysis. The rea-
son why the phylogenetic and phylogeographic analysis
was inconsistent between E-14 strains in China and
Australia remains unclear, and analysis of more se-
quences with greater detail information will yield more
precise diffusion process. In addition to spread from
Australia to India, E-14 strains seem to have been rein-
troduced into Australia from India, and the same scene
occurred among Shandong province with Guangdong
and Yunnan provinces in China. We believe that large-
scale patterns in human mobility between these loca-
tions will provide a more plausible explanation on E-14
emergence and introduction. Overall, as a well docu-
mented origin from the USA, E-14 in this area has
become silent over the past few decades. Australia may
be responsible for the transmission of E-14 in recent
years, and two regional transmissions were mainly de-
tected, with one located between Europe and Africa
countries and the other was in the Asia-Pacific region.
The results in this study are subject to a selection bias.
Sequences from GenBank are limited, especially for the
complete VP1 genes of E-14. In addition, the first E-14
sequence represents a strain isolated in 1954 in the
USA, whereas the next sequences can be obtained from
GenBank originated in 1980. Therefore, partial VP1 se-
quences were used for the ananlysis of the phylogenetic
relationships among global E-14 strains. Due to availabil-
ity of limited gene information of global E-14, further
collection and analysis, together with detailed epi-
demiological information is required to understand the
spatiotemporal dynamics of E-14 worldwide. All these
indicate that EV surveillance in most countries remains
to be strengthened and the systematic surveillance are
necessary in investigating the EV circulation and under-
standing the social burden of EV infection.
Conclusions
In this study, we collected the complete VP1 sequences
of E-14 based on the 26-year acute flaccid paralysis sur-
veillance in Shandong province, and inferred the histor-
ical background and geographic diffusion of global E-14
strains. The estimated nucleotide substitution rate for
global E-14 was 9.17 × 10−3 substitutions/site/year, and
the estimated tMRCA was August 1928. Our research
confirmed that the origin of E-14 could be in the USA,
however, regional transmissions were detected with one
located between Europe and Africa countries and the
other was in the Asia-Pacific region. Australia may be
responsible for the spread of E-14 in recent years.
Methods
Virus isolation
Stool samples were collected from children aged <15
years who were presenting acute flaccid type of paralysis
and the contacts were collected, and processed accord-
ing to standard procedures recommended by the WHO
[36]. Contacts were defined as high-risk AFP cases with
(1) <5 years of age, (2) <3 doses of oral poliovirus vac-
cine (OPV) immunization or unknown OPV history, (3)
inadequate stool specimen or (4) diagnosis of clinical
poliomyelitis. The AFP surveillance has been ongoing
without any changes since 1990 in line with the WHO
recommended standards. Three cell lines, human
rhabdomyosarcoma (RD) cell, human epidermoid car-
cinoma (Hep-2) cell and mouse cell expressing the gene
for the human cellular receptor for poliovirus (L20B)
were used for virus isolation [36]. All cell lines were
gifted from the WHO Global Poliovirus Specialized
Laboratory in the USA and were all originally purchased
from the American Type Culture Collection. A total of
200μl of chloroform-treated stool solution was added to
each of the cell culture tubes, and the inoculated cells
were examined daily. After 7 days, the tubes were frozen,
thawed, and re-passaged and another 7-day examination
was performed. Infected cell cultures were harvested
and used for further examination until complete cyto-
pathic effect (CPE) was obtained. To avoid cross con-
tamination, cell tubes of normal L20B, RD and Hep-2
cells served as negative controls. Isolates from RD or
Hep-2 cell lines were re-passaged to L20B cell line, and
were designated as NPEV if no CPE was observed.
Nucleotide sequencing and molecular typing
Total RNA was extracted from 140μl of the infected cell
culture using QIAamp viral RNA mini kit (Qiagen,
Valencia, CA, USA) according to the manufacturers’
recommended procedure. Primer pairs 008/013 [37] and
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187/011 [38] were used to amplify VP1 gene and the
combination of the two sequences yielded the entire
VP1 coding region. The reverse transcription-PCR (RT-
PCR) was performed using Access RT-PCR System
(Promega, USA) according to the manufacturers’ proce-
dures. In order to avoid cross contamination, a RT-PCR
reaction using the RNA extracted from normal RD cell
served as a blank control, and a negative control con-
taining all the components of the reaction except for the
template was also included.
PCR amplicons were visualized in agarose gels, and
positive products were purified and sequenced with the
BigDye Terminator v3.0 Cycle Sequencing kit (Applied
Biosystems, Foster City, CA). The nucleotide sequences
were analyzed by ABI 3130 genetic analyzer (Applied
Biosystems, Hitachi, Japan). The PCR products were se-
quenced in both directions to avoid possible ambiguous
nucleotides. Molecular typing based on VP1 sequences
was performed using BLAST, obtained online from the
National Center for Biotechnology Information (NCBI).
Isolates showing >75% nucleotide sequence identities
with the E-14 Tow prototype strain were designated
relative serotype [37].
Homologous comparison and phylogenetic analysis
VP1 sequences of E-14 isolated in other countries were
blasted and collected by using the nucleotide program
in the NCBI. All of the references were downloaded
with the strain name, GenBank number, geographical
region and collection date. Nucleotide sequence align-
ments were carried out by BioEdit software v7.0.5.3
[39]. Phylogenetic trees were constructed by using
MEGA v6.0 [40], using the neighbor-joining method
after estimation of genetic distance using the Kimura
two-parameter method [41]. A bootstrapping test was
performed with 1,000 duplicates, and the transition/
transversion rate was set at 2.0. To the sequences
detected in worldwide, we chose one sequence to repre-
sent sequences with similarity over 99 percentage and
identical isolation years. Recombination can sometimes
bias evolutionary relationship when constructing
phylogenetic trees [42], hence recombination of VP1
sequences was excluded based on the analysis of
SimPlot.
Bayesian Markov Chain Monte Carlo (MCMC) method
was used to analyze the evolution rate and molecular
clock phylogeny of global E-14 strains containing
Shandong isolates with the BEAST software package
version 1.7.5 [43], and the time of the most recent com-
mon ancestor (tMRCA) with 95% highest posterior dens-
ity (HPD) of global E-14 and Shandong isolates were
estimated (Additional file 3). The calibration point was
the year that each strain was isolated. We used the
general time reversible (GTR) nucleotide substitution
model with gamma-distributed rates of variable among
sites, which were identified as the best fitting model by
jModelTest v2.1.7 on the basis of Akaike Information
Criterion (AIC) [44]. Runs were performed using the
constant size, under the strict clock model and the
uncorrelated log-normal distributed (UCLD) relaxed
molecular clock model. Multiple combinations of mo-
lecular clock and coalescent models were explored, and
to select the best fitting model we used posterior-
simulation Akaike information content (AICM) [45]
and Harmonic Mean [46] model selection methods de-
scribed by Raftery and Baele, respectively. Bayesian
MCMC analyses were run with a chain of 30 million
steps and sampled every 1,000 steps. Convergence of
parameters was identified by TRACER v1.5 with the
effective sample size (ESS) exceeding 200. The Max-
imum Clade Credibility (MCC) tree was calculated by
TreeAnnotator with a burn-in period of 3,000 and then
visualized in FigTree v1.4.2.
Phylogeographic analysis
In order to infer the spatiotemporal dynamics of E-
14, the Bayesian Stochastic Search Variable Selection
(BSSVS) was used to provide evidence for statistically
supported diffusion between state variables under
BEAST v1.7.5. The results of BSSVS was summarized
using SPREAD v1.0.6 [47], a keyhole markup lan-
guage (KML) file was generated to identify the major
routes of geographic diffusion (Additional file 4).
Bayes factor (BF) test was used to select the most
probable diffusion process. To visualize the geo-
graphic dispersal of E-14, the KML file was imported
to Google™ Earth to produce a graphical animation of
the estimated spatiotemporal pathways of global E-14.
Nucleotide sequence accession numbers
The VP1 sequences of E-14 isolates described in this
study were deposited in the GenBank database under ac-
cession numbers KX840391-KX840454. All sequences
data that support the findings of this study have been
deposited in TreeBASE and are accessible through the
accession number 20306 (http://purl.org/phylo/treebase/
phylows/study/TB2:S20306).
Additional files
Additional file 1: Geographic distribution and inferred dynamics of E-14
created by the SPREAD software. (TIF 6150 kb)
Additional file 2: A graphical animation of the estimated spatiotemporal
pathways of global E-14 produced by Google™ Earth. (PDF 2809 kb)
Additional file 3: The XML file generated for the phylogenetic analysis
with BEAST software. (XML 105 kb)
Additional file 4: The KML file generated for the spatiotemporal analysis
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